Ranjita Shegokar holds a Ph.D. degree in Pharmaceutical Technology from the SNDT University,
India, and has been a postdoctoral researcher in the Department of Pharmaceutics,
Biopharmaceutics and NutriCosmetics at the Free University of Berlin, Germany.
For the last many years she has been working with various multinational pharmaceutical companies in technical/R&D leadership roles.
Currently, she serves as Chief Scientific Officer (CSO) at Capnopharm GmbH, Germany
She has authored several research articles, book chapters, and presented her research in many national/international conferences.
She has filed multiple patent applications in the area of drug delivery and targeting.
Besides that, she has edited many trending books in the area of pharmaceutical nanotechnology and drug delivery aspects.
For her research, she has received many prestigious national and international awards among them include recently
received prestigious German Innovation Award 2022. Her areas of interest include polymeric nanoparticles, nanocrystals, lipid nanoparticles (SLNs/NLCs),
nanoemulsions, cancer drug targeting and the role of excipients in delivery systems.